Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Lilly Chair and CEO Dave Ricks speaks during a press conference for Eli Lilly and Company in Houston, Texas, U.S., Sept. 23, 2025.

Antranik Tavitian | Reuters